Table 1.

Features of the patients who developed PTLD

Age at Tx, years	Primary diagnosis	Sex	Oncologic diagnosis	Diagnosis time, months	Rejection	EBV	Immunosuppression	Prognosis	Pre-transplant EBV serology
6	Congenital hepatic fibrosis	M	PTLD	60	No	Positive	Tacrolimus	Alive	Positive
1	Biliary atresia	F	PTLD	36	No	Negative	Tacrolimus	Alive	Negative
11	Autoimmune hepatitis	F	PTLD	96	No	Positive	Cyclosporine	Alive	Positive
9	Fulminan Hepatitis A	F	PTLD	7	N	Negative	Tacrolimus	Alive	Positive
1	Bile acid synthesis defect	F	PTLD	24	Yes	Negative	Tacrolimus	Alive	Negative
3	PFIC	M	PTLD	12	No	Negative	Tacrolimus	Died	Negative
4	Biliary atresia	F	PTLD	7	No	Negative	Tacrolimus	Alive	Negative

PFIC: progressive familial intrahepatic cholestasis; PTLD: post-transplant lymphoproliferative disease; EBV: Epstein-Barr virus; M: male; F: female; Tx: transplantation